Stay updated on LY3454738 in Chronic Urticaria - Clinical Trial
Sign up to get notified when there's something new on the LY3454738 in Chronic Urticaria - Clinical Trial page.

Latest updates to the LY3454738 in Chronic Urticaria - Clinical Trial page
- CheckyesterdayChange DetectedThe study record for Eli Lilly’s LY3454738 trial in adults with chronic spontaneous urticaria is now displayed, with study details and results-related information. The record indicates that the trial was terminated for lack of efficacy.SummaryDifference59%

- Check8 days agoChange DetectedThe displayed site revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe study page replaces an error screen with its standard ClinicalTrials.gov layout and displays a sitewide NIH notice about terminology changes.SummaryDifference2%

- Check22 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study record page now returns a 403 Forbidden error, replacing the previously visible trial details. The core information about the study is no longer accessible on the page.SummaryDifference18%

Stay in the know with updates to LY3454738 in Chronic Urticaria - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3454738 in Chronic Urticaria - Clinical Trial page.